Abstract
The activator protein-1 (AP-1) transcriptional complex is composed of DNA binding proteins belonging to the Jun and Fos proto-oncogene families, which play an important role in cell proliferation and transformation (reviewed in ref. 1). AP-1 activity is required to stimulate many genes that are induced following growth factor and cytokine treatment, and also is required for transformation mediated by oncogenes such as ras (2). Members of the Jun family can homodimerize or heterodimerize with each other or Fos family members, which cannot bind DNA on their own. The dimerization, which is mediated by a leucine zipper motif, allows the complex to bind to a consensus DNA sequence 5′-TGA G/C TCA-3′, termed an AP-1 site. This same sequence was found in several 12-O-tetradecanoylphorbol-13-acetate (TPA)-responsive genes and, hence, is also designated a TRE or TPA-responsive element. Heterodimers can form between c-Jun and ATF-2, a member of the CREB (CRE binding) protein family, allowing the complex to bind to CRE (cAMP regulatory element) sites, which differ from an AP-1 site by one nucleotide (3,4).
Keywords
- Sodium Dodecyl Sulfate
- Leucine Zipper Motif
- Ternary Complex Factor
- Express Renilla Luciferase
- Luciferase Measurement
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Angel P. and Karin M. (1991) The role of Jun, Fos, and the AP-1complex in cell-proliferation and transformation. Biochim. Biophys. Acta 1072, 129–157.
Schutte J., Minna J. D., and Birrer M. J. (1989) Deregulated expression of human c-jun transforms primary rat embryo cells in cooperation with an activated c-Ha-ras gene and transforms rat-la cells as a single gene. Proc. Natl. Acad. Sci.USA 86, 2257–2261.
Jvashkiv L. B., Liou H.-C, Kara C. J., Lamph W. W., Verma I. M., and Glimcher L. H. (1990) mXBP/CRE-BP2 and c-Jun form a complex which binds to the cyclic AMP, but not to the 12-O-tetradecanoyl-phorbol-13-acetate, response element. Mol. Cell Biol. 10, 1609–1621.
Hai T. and Curran T. (1991) Cross-family dimerization of transcription factors Fos/Jun and ATF/CREB alters DNA binding specificity. Proc. Natl. Acad. Sci. USA 88, 3720–3724.
Hsu J.-C, Cressman D. E., and Taub R. (1993) Promoter-specific trans-activation and inhibition mediated by JunB. Cancer Res. 53, 3789–3794.
Karin M. (1995) The regulation of AP-1 activity by mitogen-activated protein kinases. J. Biol. Chem. 270, 16,483–16,486.
Marais R.and Marshall C.J. (1996) Control of the ERK MAP kinase cascade by Ras and Raf. Cancer Surveys 27, 101–125.
Kyriakis J. M. and Avruch J. (1996) Sounding the alarm: protein kinase cascades activated by stress and inflammation. J. Biol. Chem. 271, 24,313–24,316.
Woodgett J. R., Avruch J., and Kyriakis J. (1996) The stress activated protein kinase pathway. Cancer Surveys 27, 127–138.
Zinck R., Hipskind R. A., Pingoud V., and Nordheim A. (1993) c-fos transcrip-tional activation and repression correlate temporally with the phosphorylation status of TCF. EMBO J. 12, 2377–2387.
Treisman R. (1996) Regulation of transcription by MAP kinase cascades. Curr.Opin. Cell Biol. 8, 205–215.
Whitmarsh A. J., Shore P., Sharrocks A. D., and Davis R.J. (1995) Integration of MAP kinase signal transduction pathways at the serum response element. Science 269,403–407.
Iordanov M., Bender K., Ade T., Schmid W., Sachsenmaier C, Engel K., Gaestel M., Rahmsdorf H. J., and Herrlich P. (1997) CREB is activated by UVC through a p38/HOG-l-dependent protein kinase. EMBO J. 16, 1009–1022.
van Dam H., Duyndam M., Rottier R., Bosch A., de Vries-Smits L., Herrlich P., Zantema A., Angel P., and van der Eb A. J. (1993) Heterodimer formation of cJun and ATF-2 is responsible for induction of c-jun by the 243 amino acid E1 A protein. EMBO J. 12, 479–487.
Derijard B., Hibi M., Wu I.-H., Barrett T., Su B., Deng T., Karin M., and Davis R. J. (1994) JNK1: a protein kinase stimulated by UV light and Ha-ras that binds and phosphorylates the c-jun activation domain. Cell 76, 1025–1037.
Kyriakis J.M., Banerjee P., Nikolakaki E., Dai T., Rubie E. A., Ahmad M.F., Avruch J., and Woodgett J. R. (1994) The stress-activated protein kinase subfamily of c-Junkinases. Nature 369, 156–160.
Gupta S., Campbell D., Derijard B., and Davis R. J. (1995) Transcription factor ATF2 regulation by the JNK signal transduction pathway. Science 267, 389–393.
Jiang Y., Chen C, Li Z., Guo W., Gegner J. A., Lin S., and Han J. (1996) Characterization of the structure and function of a new mitogen-activated protein kinase (p38p). J. Biol Chem. 271, 17,920–17,926.
Jonk L. J. C, Itoh S., Heldin C.-H., ten Dijke P., and Kruijer W. (1998) Identification and functional characterization of a Smad binding element (SBE) in the JunB promoter that acts as a transforming growth factor-β, activin, and bone mor-phogenetic protein-indueible enhancer. J. Biol Chem. 273, 21,145–21,152.
Swanson K. D., Taylor L. K., Haung L., Burlingame A. L., and Landreth G. E. (1999) Transcription factor phosphorylation by pp90rsk2: identification of Fos kinase and NGFI-B kinase I as pp90rsk2. J. Biol. Chem. 274, 3385–3395.
Keeton M.R., Curriden S.A., vanZonneveld A.J., and Loskutoff D.J.(1991) Identification of regulatory sequences in the type 1 plasminogen activator inhibitor gene responsive to transforming growth factor beta. J. Biol. Chem. 266, 23,048–23,052.
Campbell C.E., Flenniken A.M., Skup D., and Williams B.R.G. (1991) Identification of a serum-and phorbol ester-responsive element in the murine tissue inhibitor of metalloproteinase gene. J. Biol. Chem. 266, 7199–7206.
Kim S.-J., Angel P., Lafyatis R., Hattori K., Kim K. Y., Sporn M. B., Karin M., and Roberts A. B. (1990) Autoinduction of transforming growth factor beta 1 is mediated by the AP-1 complex. Mol.Cell Biol. 10, 1492–1497.
Angel P., Hattori K., Smeal T., and Karin M. (1988) The jun proto-oncogene is positively autoregulated by its product, Jun/AP-1. Cell 55, 875–885.
Chung K. Y., Agarwal A., Uitto J., and Mauviel A. (1996) An AP-1 binding sequence is essential for regulation of the human alpha2(I) (C0L1A2) promoter activity by transforming growth factor-beta. J. Biol. Chem. 271, 3272–3278.
Jin G. and Howe P. H. (1998) Regulation of clusterin gene expression by transforming growth factor beta. J. Biol. Chem. 272, 26,620–26,626.
Dean D. C, Bowlus C. L., and Bourgeois S. (1987) Cloning and analysis of the promoter region of the human fibronectin gene. Proc.Natl. Acad. Sci.USA 84, 1876–1880.
Kim S.-J., Wagner S., Liu F., O’ Reilly M. A., Robbins P. D., and Green M. R. (1992) Retinoblastoma gene product activates expression of the human TGF-β2 gene through transcription factor ATF-2. Nature 358, 331–334.
Hocevar B. A., Brown T. L., and Howe P. H. (1999) TGF-β induces fibronectin synthesis through a c-Jun N-terminal kinase-dependent, Smad4-independent pathway. EMBO J. 18, 1345–1356.
Ryder K., Lau L. F., and Nathans D. (1988) A gene activated by growth factors is related to the oncogene v-jun. Proc. Natl. Acad. Sci. USA 85, 1487–1491.
Sambucetti L. C, Schaber M., Kramer R., Crowl R., and Curran T.(1986) The fos gene product undergoes extensive post-translational modification in eukary-otic but not in prokaryotic cells. Gene 43, 69–11.
Danielson P. E., Forss-Petter S., Brow M. A., Calavetta L., Douglass J., Milner R.J., and Sutcliffe J. G. (1988) plB15: acDNA clone of the rat mRNA encoding cyclophilin. DNA 7, 261–267.
Pertovaara L., Sistonen L., Bos T. J., Vogt P. K., Keski-Oja J., and Alitalo K. (1989) Enhanced jun gene expression is an early genomic response to transforming growth factor beta stimulation. Mol. Cell Biol. 9, 1255–1262.
Mauviel A., Chung K.-Y., Agarwal A., Tamai K., and Uitto J. (1996) Cell-specific induction of distinct oncogenes of the Jun family is responsible for differential regulation of collagenase gene expression by transforming growth factor β in fibroblasts and keratinocytes. J. Biol. Chem. 271, 10,917–10,923.
Leof E. B., Proper J. A., Goustin A. S., Shipley G. D., DiCorleto P. E., and Moses H. L. (1986) Induction of c-sis mRNA and activity similar to platelet-derived growth factor by transforming growth factor beta: a proposed model for indirect mitogenesis involving autocrine activity. Proc. Natl. Acad. Sci.USA 83. 2453–2457.
Maniatis T., Fritsch E. F., and Sambrook J., eds. (1989) Molecular Cloning:A Laboratory Manual, 2nd ed., Cold Spring Harbor Laboratory Plainview, NY. pp. 7.46–7.48.
Hocevar B. A. and Howe P. H. (1996) Isolation and characterization of mutant cell lines defective in transforming growth factor beta signaling. Proc. Natl. Acad. Sci.USA 93,7655–7660.
Liu F., Hata A., Baker J. C, Doody J., Carcamo J., Harland R. M., and Massague J. (1996) A human Mad protein acting as a BMP-regulated transcrip-tional activator. Nature 381, 620–623.
Zhang Y., Feng X.-H., and Derynck R. (1998) Smad3 and Smad4 cooperate with c-Jun/c-Fos to mediate TGF-β-induced transcription. Nature 394, 909–913.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2000 Humana Press Inc.
About this protocol
Cite this protocol
Hocevar, B.A., Howe, P.H. (2000). Regulation of AP-1 Activity by TGFβ. In: Howe, P.H. (eds) Transforming Growth Factor-Beta Protocols. Methods in Molecular Biology™, vol 142. Humana Press. https://doi.org/10.1385/1-59259-053-5:97
Download citation
DOI: https://doi.org/10.1385/1-59259-053-5:97
Publisher Name: Humana Press
Print ISBN: 978-0-89603-646-8
Online ISBN: 978-1-59259-053-7
eBook Packages: Springer Protocols